| dbo:abstract
|
- Jochen Reiser (born June 23, 1971 in Pforzheim, Germany) is a physician-scientist and a healthcare leader. He is the Ralph C Brown MD Professor and the Chairman of Medicine at Rush University Medical Center. Dr. Reiser's research has provided important mechanistic insights into the molecular pathogenesis of kidney diseases. Dr. Reiser discovered the role of suPAR (soluble urokinase plasminogen activator receptor) as a global, circulating risk factor for chronic kidney disease (CKD) as well as for acute kidney injury (AKI). suPAR is investigated as potential causative agent contributing to many kidney diseases including focal segmental glomerulosclerosis (FSGS). These studies have broad clinical significance and lay the foundation for creation of novel diagnostics and pharmaco-therapeutics with potential benefit for a large patient population. His studies on suPAR molecule were featured in Science in 2018. Dr. Reiser has been an advocate of science and innovation for two decades and was named as an inventor on multiple patents. He is co-founder of Cambridge, MA-based Walden Biosciences, an ARCH Venture Partners joint-venture biopharmaceutical portfolio company dedicated to develop first-in-class therapeutics for kidney diseases. (en)
|
| dbo:academicDiscipline
| |
| dbo:almaMater
| |
| dbo:birthDate
| |
| dbo:birthPlace
| |
| dbo:knownFor
| |
| dbo:nationality
| |
| dbo:thumbnail
| |
| dbo:wikiPageExternalLink
| |
| dbo:wikiPageID
| |
| dbo:wikiPageLength
|
- 16028 (xsd:nonNegativeInteger)
|
| dbo:wikiPageRevisionID
| |
| dbo:wikiPageWikiLink
| |
| dbp:almaMater
| |
| dbp:birthDate
| |
| dbp:birthPlace
| |
| dbp:field
| |
| dbp:knownFor
|
- Podocytes, Glomerular diseases, Chronic kidney disease , Focal segmental glomerulosclerosis , Soluble urokinase plasminogen activator receptor . (en)
|
| dbp:name
| |
| dbp:nationality
|
- United States/Germany (en)
|
| dbp:prizes
|
- Young Investigator Award ; Scholar Award for Amino Acid Research ; Provost’s Award for Scholarly Activity ; Franz Volhard Award ; Research Faculty Award . (en)
|
| dbp:website
| |
| dbp:wikiPageUsesTemplate
| |
| dbp:workInstitution
| |
| dcterms:subject
| |
| schema:sameAs
| |
| rdf:type
| |
| rdfs:comment
|
- Jochen Reiser (born June 23, 1971 in Pforzheim, Germany) is a physician-scientist and a healthcare leader. He is the Ralph C Brown MD Professor and the Chairman of Medicine at Rush University Medical Center. Dr. Reiser's research has provided important mechanistic insights into the molecular pathogenesis of kidney diseases. Dr. Reiser discovered the role of suPAR (soluble urokinase plasminogen activator receptor) as a global, circulating risk factor for chronic kidney disease (CKD) as well as for acute kidney injury (AKI). suPAR is investigated as potential causative agent contributing to many kidney diseases including focal segmental glomerulosclerosis (FSGS). These studies have broad clinical significance and lay the foundation for creation of novel diagnostics and pharmaco-therapeutics (en)
|
| rdfs:label
| |
| owl:sameAs
| |
| prov:wasDerivedFrom
| |
| foaf:depiction
| |
| foaf:homepage
| |
| foaf:isPrimaryTopicOf
| |
| foaf:name
| |
| is dbo:wikiPageWikiLink
of | |
| is foaf:primaryTopic
of | |
